You are viewing a limited version of this profile. To access i3's full capabilities.
Bayer
Save
Company logo (jpg or png)
Parent company

Short description

Developer of new molecules for use in innovative products and solutions to improve the health of humans, animals and plants

Founded in 1863
Founded in

Company type Acquired Public ()
Company type

Industry Group

Sector

TRL Range 9
TRL 1 Basic research
TRL 2 Technology formulation
TRL 3 Applied research
TRL 4 Small scale prototype
TRL 5 Large scale prototype
TRL 6 Prototype system
TRL 7 Demonstration system
TRL 8 First of a kind commercial system
TRL 9 Full commercial application
TRL Range

Ticker

Headquarters Germany Leverkusen, Germany
Address
City
State
Zip
Country

Parent Companies

Traction
  • 1 M&A items
tags
Similar companies
Customers
Save
Date Company
Partnerships
Save
Date Partner Type
05/27/2024
Pairwise Pairwise
After successfully launching the first CRISPR food in North America, Pairwise is now licensing the leafy greens to the global agriculture company to carry its first consumer product forward at scale via an exclusive product licence.
View source    
Confirmed by Pairwise
Licensor
Investment Rounds
Save

IPO INFORMATION

Date

IPO status

IPO Type

Amount

Initial shares

Ticker symbol

Exchange listed

Prospectus URL

Prospectus

Source URL

Source

Description

Date Investors Type Amount
04/17/2018 Temasek Holdings Temasek Holdings (1)
Post-money valuation of
Temasek is buying a 3.6% stake in the company, via post-IPO equity investment.
PIPE $4,900,000,000
Click to add IPO information
Products
Save
Product image Name Product status Revenue model Cost metrics
You are viewing a limited version of this profile. To access i3's full capabilities.
Back to top

Preload svg text font